Latest Resources News

Robex Resources confirms steady progress at its Kiniero Gold Project in Guinea, maintaining schedule and budget for first gold production in late 2025. Key construction milestones and drilling activities highlight the project’s momentum.

Ora Banda Mining Ltd delivered a standout FY25 with net profit soaring 575% to $186 million, driven by record gold production and successful underground mine expansions. The company sets ambitious FY26 targets amid strong operational momentum.

Veris Limited has reported a significant turnaround in FY25, posting a $2 million profit before tax on $97.2 million revenue, driven by growth in digital and spatial advisory services and strategic acquisitions.

Critica Limited has dispatched an upgraded composite concentrate from its Jupiter Project to ANSTO for independent hydrometallurgical testing, aiming to produce a Mixed Rare Earth Carbonate (MREC). Complementary assessments by Minutech will help optimise processing routes and support upcoming feasibility studies.

Miramar Resources has partnered with Sumitomo Metal Mining Oceania in a multi-million-dollar joint venture to explore for large-scale nickel-copper-platinum group element deposits at the Bangemall Projects in Western Australia.

West African Resources has reported a robust first half of 2025, delivering A$215 million in net profit after tax on the back of strong gold production and sales.

Western Gold Resources has kicked off a major 35,300-metre grade control and infill drilling program at its Gold Duke Project, aiming to de-risk operations and support a mining start in late Q4 2025.

AUB Group Limited delivered a robust FY25 performance, with underlying NPAT rising 17.1% to AUD 200.2 million, driven by strategic acquisitions and margin improvements. The company’s aggressive UK retail expansion and diversified portfolio underpin a confident FY26 outlook.

Metals X Limited reported a robust half-year to June 2025 with profit after tax soaring 256% to $52.9 million, driven by higher tin sales and prices from its Renison joint venture. The company also progressed key projects and deepened strategic investments while reinforcing its ESG and safety frameworks.

Actinogen Medical reported a $14.7 million net loss for FY25 while progressing its lead drug Xanamem through pivotal Alzheimer’s and depression trials, with interim results expected in January 2026. The company has secured funding through mid-2026 and is preparing for commercialization.

Supply Network Limited reported a robust 15.5% revenue increase to $349.9 million and a 21.2% rise in profit after tax to $40 million for FY2025, alongside a higher fully franked final dividend of 38 cents per share.

Symal Group Limited reported a robust FY25 with revenue and earnings growth exceeding Prospectus forecasts, underpinned by strategic acquisitions and a strong pipeline of contracts.